1001 S Main Street STE 500 Kalispell, MT
24/7 Urgent Call: +1-406-2251570

Clinical Laboratory Billing: CLFS, CLIA, PAMA, and the 14-Day Rule

17 min read Medical Billing 2026 Guide
A flat illustration of a laboratory technician testing blood samples beside a claim form and a microscope, no text in the image

Direct answer: A clinical laboratory claim is paid from the Clinical Laboratory Fee Schedule (CLFS), not the physician fee schedule, and the amount Medicare pays comes from the weighted median of private payer rates set under the Protecting Access to Medicare Act (PAMA). Whether the claim is paid at all is decided earlier, by the order: the requisition, the ordering diagnosis and the order set decide which tests may be billed, and the diagnosis must support the test under the applicable national or local coverage determination, or the claim denies as not medically necessary. The testing site must hold a valid CLIA certificate that matches the complexity of the test, and the date of service is usually the date the specimen was collected, unless the 14-day rule or one of the molecular exceptions moves it to the date the test was performed.

THE CLFS AND HOW MEDICARE PAYS FOR LAB TESTS

Most clinical diagnostic laboratory tests are listed by HCPCS code on the CLFS, and the test code decides which rate applies, so the code on the claim matters more than the amount on the charge slip. Laboratories must accept assignment for CLFS services, which means they accept the Medicare allowed amount as payment in full. Most CLFS services carry no patient deductible or coinsurance, which is different from most other Part B services, so do not bill the patient a deductible or coinsurance for a CLFS service unless the payer says otherwise. The professional component of a laboratory test, such as a pathologist's interpretation of the result, is not paid from the CLFS; it is paid under the physician fee schedule, and it is billed separately from the technical component. PAMA changed how the CLFS rates are set: for most tests, the rate is the weighted median of the private payer rates that applicable laboratories reported to CMS during a data collection period, and the schedule is updated every three years for most tests. Congress delayed the phase-in reductions to those rates several times, and no PAMA phase-in reduction applies in the 2026 CLFS. Reductions resume on 1 January 2027, capped at 15 percent per test per year, as verified at writing time. No CLFS rate is quoted in this article, because rates vary by locality and schedule, and the current CMS CLFS file is the source to check before quoting a rate.

THE ORDER DECIDES WHAT MAY BE BILLED

Laboratory billing starts with the order, not with the analyzer. The requisition must show the test ordered, the ordering physician, the ordering diagnosis, and the date, and only the ordering physician can order the test. Standing orders and order sets are acceptable only when they are specific, signed, and tied to a clinical indication for that patient; a generic order set that adds tests for every patient is not an order for every patient. The diagnosis on the order must support the test under the applicable national coverage determination (NCD) or local coverage determination (LCD), because each covered test carries a list of diagnosis codes that support medical necessity. An order with a diagnosis outside that list denies as not medically necessary, and the denial code on the remittance tells you whether the fix is a corrected claim, a different diagnosis that the record actually supports, or an appeal, as explained in the Claim Denial Codes: Complete Guide. Do not change the diagnosis to fit the test, and do not add tests the physician did not order, because the record must support everything on the claim. When a test is expected to be denied as not medically necessary, an Advance Beneficiary Notice of Noncoverage (ABN) signed before the test lets the laboratory bill the patient; without a valid ABN, the laboratory cannot shift liability for a denied test to the patient. Reflex tests and add-on tests ordered by protocol are billable only when the protocol is documented, the result actually triggers the reflex test, and the payer covers the additional test.

CLIA CERTIFICATES AND THE QW MODIFIER

A lab claim needs a valid, current CLIA certificate behind the test. CLIA is the federal program, run by CMS, that sets quality standards for testing human specimens, and CMS edits lab claims at the certificate level, so Medicare pays only for tests performed in a facility with a valid, current certificate. The certificate must match the highest test complexity the site performs, and each certificate is valid for two years and must be renewed.

CertificateWhat it allowsValidity
Certificate of WaiverWaived tests only2 years
Certificate of Provider-Performed Microscopy (PPM)Waived tests plus provider-performed microscopy2 years
Certificate of RegistrationLets the laboratory operate while it applies for a Certificate of Compliance or a Certificate of Accreditation2 years
Certificate of ComplianceModerate and high complexity tests, surveyed by CMS2 years
Certificate of AccreditationModerate and high complexity tests, surveyed by an approved accrediting organization2 years

A test performed under the wrong certificate denies, and an expired certificate denies the same way, so the certificate number and its expiration date belong on the pre-claim checklist, not on the denial worklist. The QW modifier belongs on the same checklist: append QW to the CPT code for a CLIA-waived test, such as a rapid strep test or a urine dipstick performed at the point of care, to show that the test was performed under a waiver certificate. Without QW on a waived test, the payer cannot see from the code alone that the test was waived, and the claim can deny. Do not append QW to a test that is not waived, because the modifier describes the test's CLIA category, not the place where it was performed.

PANEL CODES AND COMPONENT RULES

Organ and disease panels are single CPT codes that report a defined set of component tests, and a panel code is reportable only when every component was performed and resulted. If one component was not performed, the panel code cannot be billed, and the laboratory bills the individual component codes for the tests that were actually performed instead. Do not unbundle a panel into its components when all components were performed, because the panel code is the correct code in that case.

Panel codePanelComponents that must all be performed
80048Basic Metabolic PanelCalcium, carbon dioxide, chloride, creatinine, glucose, potassium, sodium, and urea nitrogen
80053Comprehensive Metabolic PanelThe 8 basic metabolic components plus albumin, total bilirubin, alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, and total protein
80061Lipid PanelTotal cholesterol, high-density lipoprotein cholesterol, and triglycerides
80050General Health PanelComprehensive metabolic panel, complete blood count, and thyroid stimulating hormone
80055Obstetric PanelComplete blood count, hepatitis B surface antigen, HIV, rubella, syphilis, blood type and Rh, and antibody screen

A common failure is a panel that is missing one component because a reagent was out of stock, a sample was insufficient, or one result was never reported. The claim still cannot carry the panel code, and the fix is to bill the individual codes for the components that were performed and resulted, not to bill the panel code and hope the payer does not notice. Check panel completeness before the claim goes out, because the payer edits check that all components are present.

REFERENCE LABS AND THE ANTI-MARKUP RULE

When a laboratory sends a specimen to a reference laboratory, only one entity bills Medicare for the test. The performing laboratory usually bills directly, and an independent laboratory that refers a test to another independent laboratory may bill for the referred test when both laboratories are enrolled as independent clinical laboratories. When a billing entity bills Medicare for a test performed by another laboratory, the anti-markup rule applies: Medicare limits payment to the lowest of the billing entity's charge, the amount the billing entity paid the performing laboratory, or the applicable fee schedule amount, so the billing entity cannot add a markup to another laboratory's work. Keep the requisition, the reference laboratory's report, and the amount paid to the performing laboratory on file, because the claim must show the performing laboratory's information where required, and an audit will ask for the amount actually paid. A markup on a referred test is not a billing strategy; it is a denial and a compliance risk.

DATE OF SERVICE AND THE 14-DAY RULE

The date of service is the date the specimen was collected, under 42 CFR 414.510, and the date the test was run or the date the report was issued does not change it. If a specimen is collected over a period that spans two calendar days, the date of service is the date the collection ended. Tests performed for a hospital inpatient are bundled into the hospital's payment and are not separately paid under the CLFS, and tests for a hospital outpatient are generally packaged into the outpatient payment, which is why the date of service decides who bills. The 14-day rule is the exception that lets the performing laboratory bill Medicare directly instead of the hospital, and it applies to a test performed on a stored specimen, stored for 30 calendar days or fewer from the date it was collected, only when all five of these conditions are met: the test was ordered by the patient's physician at least 14 days following the date of the patient's discharge from the hospital; the specimen was collected while the patient was undergoing a hospital surgical procedure; it would have been medically inappropriate to have collected the sample other than during the hospital procedure for which the patient was admitted; the results of the test do not guide treatment provided during the hospital stay; and the test was reasonable and medically necessary for the treatment of an illness. If any one condition fails, the exception does not apply, the date of service reverts to the collection date, and the hospital bills. Meeting the 14-day order requirement is only one of the five conditions, and in practice it is usually the one that decides the case. A second exception covers molecular pathology tests, tests designated by CMS as Advanced Diagnostic Laboratory Tests (ADLTs), cancer-related protein-based Multianalyte Assays with Algorithmic Analyses (MAAAs), and the test described by CPT code 81490, under 42 CFR 414.510(b)(5): for these tests, the date of service is the date the test was performed when the specimen was collected during a hospital outpatient encounter, the test was performed following the patient's discharge from the hospital outpatient department, it was medically appropriate to have collected the sample during the outpatient encounter, the results do not guide treatment provided during the outpatient encounter, and the test was reasonable and medically necessary. Molecular pathology tests performed by blood banks or centers are excluded from this exception. The date of service rule covers a clinical laboratory test and the technical component of a pathology service; it does not set the date of service for the pathologist's professional interpretation.

WORKED EXAMPLE, ALL FIGURES ILLUSTRATIVE

Every date and outcome in this example is illustrative. First, a physician orders a comprehensive metabolic panel, CPT 80053, for a patient, and the laboratory runs 13 of the 14 components because one reagent is out of stock. The panel code 80053 cannot be billed, because not every component was performed and resulted, so the laboratory bills the individual component codes for the 13 tests that were performed. Second, a patient is discharged after surgery on 1 March, and the surgeon orders a test on a specimen collected during the surgery on 25 March, which is more than 14 days after discharge, with results that will not guide treatment during the stay. All five conditions of the 14-day rule are met, so the date of service is the date the test was performed, not the collection date, and the laboratory bills Medicare directly under the CLFS. Third, a physician office laboratory holding a Certificate of Waiver performs a rapid strep test and bills the test code with the QW modifier, which shows the payer that the test was waived; the same claim without QW would risk denial. Fourth, a practice sends a specialized test to a reference laboratory, pays the reference laboratory for the work, and bills Medicare for the test; the anti-markup rule limits the payment to the lowest of the practice's charge, the amount paid to the reference laboratory, or the fee schedule amount, so the practice cannot add a markup.

COMMON MISTAKES THAT TRIGGER DENIALS

The first common mistake is billing a panel code when a component is missing, instead of billing the individual component codes for the tests that were performed. The second is billing a test with a diagnosis outside the NCD or LCD list, which denies as not medically necessary. The third is billing under the wrong CLIA certificate, or with a certificate that has expired. The fourth is omitting the QW modifier on a waived test. The fifth is using the test date or the report date as the date of service instead of the specimen collection date. The sixth is applying the 14-day rule when one of the five conditions fails, which is usually the requirement that the specimen was collected during a hospital surgical procedure. The seventh is marking up a reference laboratory test, which the anti-markup rule does not pay. The eighth is billing the professional component of a test from the CLFS, or billing a hospital inpatient test separately when it is bundled into the hospital's payment. The ninth is billing tests the physician did not order, or adding tests from an order set that was never signed for that patient. Each of these mistakes is preventable by checking four things before the claim goes out: the order and the diagnosis, the CLIA certificate, the panel completeness, and the date of service.

CHECKLIST

Confirm the requisition shows the test, the ordering physician, the ordering diagnosis and the date, and that any standing order or order set is specific and signed for that patient. Check the diagnosis against the applicable NCD or LCD list before the claim goes out, and obtain a signed ABN before the test when a denial as not medically necessary is expected. Confirm the CLIA certificate is current, matches the highest complexity of the test, and covers the testing site. Append the QW modifier to every CLIA-waived test, and never append it to a test that is not waived. Confirm every component of a panel was performed and resulted before billing the panel code, and bill the individual component codes when a component is missing. Set the date of service to the specimen collection date unless an exception applies, and check all five conditions of the 14-day rule before using the test performance date. For a molecular test, an ADLT, a cancer-related protein-based MAAA, or CPT 81490, check the conditions of 42 CFR 414.510(b)(5) before using the performance date. Confirm who bills when a test is sent to a reference laboratory, and keep the amount paid to the performing laboratory on file for the anti-markup rule. Remember that most CLFS services carry no patient deductible or coinsurance, and bill the professional component under the physician fee schedule, not the CLFS. If a claim denies, read the denial code first, because it tells you whether the fix is a corrected claim or an appeal, as explained in the Claim Denial Codes: Complete Guide, and when an evaluation and management service is billed on the same day as a laboratory visit, append modifier 25 only when the service is significant and separately identifiable, as explained in the Modifier 25 Denial Appeal guide.

FREQUENTLY ASKED QUESTIONS

What is the CLFS? The Clinical Laboratory Fee Schedule is the Medicare fee schedule that pays most clinical diagnostic laboratory tests, listed by HCPCS code, and it is separate from the physician fee schedule. How does PAMA set CLFS rates? Under the Protecting Access to Medicare Act, most CLFS rates are the weighted median of the private payer rates that applicable laboratories reported to CMS, updated every three years for most tests. What happens to CLFS rates in 2027? No PAMA phase-in reduction applies in the 2026 CLFS, and reductions resume on 1 January 2027, capped at 15 percent per test per year, as verified at writing time, so check the current CMS CLFS file before quoting a rate. What is a CLIA certificate and which one do I need? CLIA is the federal program that sets quality standards for testing human specimens, and the certificate must match the highest test complexity the site performs, from a Certificate of Waiver for waived tests up to a Certificate of Compliance or Accreditation for moderate and high complexity tests, with each certificate valid for two years. When do I use the QW modifier? Append QW to the CPT code for a CLIA-waived test to show it was performed under a waiver certificate, and never append it to a test that is not waived. When can I bill a panel code? A panel code such as 80048, 80053, 80061, 80050 or 80055 is reportable only when every component was performed and resulted, and when a component is missing, bill the individual component codes for the tests that were performed. What is the date of service for a lab test? Usually the date the specimen was collected, under 42 CFR 414.510, and when collection spans two calendar days, the date of service is the date the collection ended. What is the 14-day rule? It is the exception for a test performed on a stored specimen, stored for 30 calendar days or fewer, when the test was ordered at least 14 days after the patient's hospital discharge and four other conditions are met, and when it applies the date of service is the date the test was performed. What is CPT 81490 and why does it matter for the date of service? CPT 81490 is one of the tests covered by the molecular exception at 42 CFR 414.510(b)(5), along with ADLTs, molecular pathology tests and cancer-related protein-based MAAAs, for which the date of service is the date the test was performed when all the stated conditions are met. Who bills when a test is sent to a reference laboratory? Usually the performing laboratory bills directly, and when another entity bills for the referred test, the anti-markup rule limits payment to the lowest of the billing entity's charge, the amount paid to the performing laboratory, or the fee schedule amount. Does the patient owe a deductible or coinsurance for a lab test? Most CLFS services carry no patient deductible or coinsurance, which is different from most other Part B services. What happens if the diagnosis does not support the test? The claim denies as not medically necessary under the applicable NCD or LCD, and an ABN signed before the test is what lets the laboratory bill the patient.

A note on codes and coverage: This article is educational information about medical billing rules, not legal, financial or compliance advice. Codes, coverage rules and payer policies vary and change over time, and the PAMA phase-in schedule has been changed by Congress several times, so always verify the current rule against the CMS manuals, the current CLFS file and the specific payer policy before acting. The worked example uses illustrative dates and outcomes only, and no payment rates are quoted, because CLFS rates vary by locality and schedule.

Having trouble with lab billing, or with CLFS, CLIA or date of service denials? Neximed Billing provides denial management, corrected claim review and billing workflow support. Contact us at info@neximedbilling.com or +1-406-2251570.

Related reading: Claim Denial Codes: Complete Guide · Modifier 25 Denial Appeal · Modifier 51: Multiple Procedures Billing